Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Gómez-Román, J; Restrepo, JC; González, LM; González-Rodríguez, L; Lacombe-Antoneli, A; Gutiérrez-Martín, Y; de la Maya, MD; Mesegué, M; Dapena, JL; Carbone, A; Martínez, BG; Molinos, FL; Honrubia, AM; García, MA; Morín, MG; Noguera, SN; de Ilurdoz, MS; Astigarraga, I; Fernández, MB; Amorós, JV; Regueiro, A; Orellana, MR; Soler, JLF; Muñiz, SG; Nieto, AC; Español, MT; Méndez, HG; Vagace, JM; Gervasini, G.

Phenotype-Specific Pharmacogenetic Patterns of Methotrexate Neurotoxicity in Pediatric Acute Lymphoblastic Leukemia

Journal of Clinical Medicine. 2026; 15(17): [doi:10.3390/jcm15176877]

Haveman, LM; Hjalgrim, LL; Fernández, CM; Marec-Berard, P; Laurence, V; Merks, JHM; Morales, CV; Berlanga, P; Gaspar, N; Strauss, SJ; Brennan, B; Luksch, R.

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients

CANCER TREATMENT REVIEWS. 2026; 149: [doi:10.1016/j.ctrv.2026.103196]

Pallarés-Carratalá, V; Justel-Pérez, JP; Cinza-Sanjurjo, S; López-Fernández, T; Yedro, MT; Garcia, AR; Kwifatie, AKN; Peña-López, J; Zamora-Auñón, P; Higuera, O; de Paz-Arias, R; Córdoba-Mascuñano, R; Pascual-Izquierdo, C; Ciérvide-Jurío, R; Moliner, P; Paños-Babi, M; Rodriguez-Paz, DD; Mazón-Ramos, P.

SEMERGEN Position Statement on the management of the Oncologic Patient: Comprehensive Approach to Cardiotoxicity in Primary Care

Medicina de Familia-SEMERGEN. 2026; 52(6): [doi:10.1016/j.semerg.2026.102780]

Alegre-Amor, A; Bailén-Almorox, R; Bastos-Oreiro, M; Foncillas, MA; Martínez-Barranco, P; Morado-Arias, M; Pardo-Gambarte, L; Serí-Merino, C; Solán-Blanco, L; Barber-Turro, I; Cedillo, A; Benito-Parra, L; Jiménez-Yuste, V; Hernández-Rivas, A.

Burnout and workload among hematologists in the Community of Madrid (Spain): a survey based on the Copenhagen burnout inventory

Frontiers in Public Health. 2026; 14: [doi:10.3389/fpubh.2026.1905977]

Ribera, JM; Torrent, A; Morgades, M; Barrena, S; Ribera, J; Genesca, E; González-Campos, J; Martinez-Cibrian, N; Montesinos, P; Hernández-Sánchez, A; Barba, P; Zapico, E; Sánchez, R; Novo, A; Sitges, M; Maluquer, C; Such, E; Botella, C; de Llano, MPQ; Cabrero, M; Vicent, A; de Ugarriza, PL; Tormo, M; González-González, BJ; García-Cadenas, I; Rodríguez-Medina, C; Martinez-Sánchez, P; Bermúdez, A; Gómez-Centurión, I; Herrero, M; Ciudad, J; Navas-Acosta, J; Hermosín, L; Serrano, J; Raposo, JA; Solán, L; Roldán-Galiacho, V; de Laiglesia, A; Gómez-Pérez, L; Solé-Rodríguez, M; Casado, MS; Llorente, L; Barrios, D; Vall-llovera, F; Algarra, JL; Amador, ML; Garcia-Boyero, R; Cladera, A; Bergua, J; Calasanz, MJ; Granada, I; Feliu, E; Hernández-Rivas, JM; Orfao, A.

Genetics and MRD for therapy allocation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia

BLOOD. 2026; 148(8): 939-956 Nº de citas: 1 [doi:10.1182/blood.2025032645]

Fleischhauer, K; Toffalori, C; Cugnata, F; Hofmann, JA; Orofino, G; Lorentino, F; Ahci-Hanci, M; Lange, V; Müller, CR; Kunadt, D; Bornhäuser, M; Sanz, G; Soiffer, R; Waterhouse, M; Giaccone, L; Ali, H; Nachtkamp, K; Bacigalupo, A; Bonifazi, F; Luznik, L; Facchini, L; Bramanti, S; Nagler, A; Saccardi, R; Milano, F; Zallio, F; Pierini, A; Mohty, M; Flomenberg, N; Takaori-Kondo, A; Vey, N; Teshima, T; Kröger, N; Laperche, CM; Andreani, M; Stanghellini, MTL; Peccatori, J; Di Serio, C; Kobbe, G; Al Malki, MM; Bruno, B; Zeiser, R; Lindsley, RC; Sanz, J; Beelen, D; Stölzel, F; Sauter, J; Schmidt, AH; Ciceri, F; Vago, L.

Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation

JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(23): 2221-2232 Nº de citas: 3 [doi:10.1200/JCO-26-00113]

Budde, LE; Kamdar, M; Assouline, SE; Chavez, JC; Ghosh, N; Ollila, TA; Hodson, DJ; Modi, D; Bastos-Oreiro, M; Naik, SG; Nakhoda, SK; Batlevi, CL; Wang, J; Makadia, S; Kwan, A; Penuel, E; Jing, J; Wu, H; Ead, W; Pham, S; To, I; Wei, MC; Wang, ML.

Mosunetuzumab plus polatuzumab vedotin for relapsed/refractory MCL after BTK inhibitor therapy a phase 2 study

BLOOD. 2026; 148(6): 682-692 Nº de citas: 6 [doi:10.1182/blood.2025032422]

Bringas, M; Echavarría, I; Polo, C; Jiménez-Alduán, N; Flores, C; Muñoz, A; Ortega, L; Torres, G; Soto-Alsar, J; Calvo, A; Alfonso, PG; Pajares, JA; Suárez-González, J; del Monte-Millán, M; Massarrah, T; de la Peña, FA; Martín, M; Márquez-Rodas, I.

Mainstream and fast-track genetic testing in pancreatic cancer patients and its impact on treatment: our experience in a tertiary hospital in Spain

Familial Cancer. 2026; 25(3): [doi:10.1007/s10689-026-00595-8]

Alsina, L; Passini, VC; Colino, CG; Guillermo, AL; Bastos-Oreiro, M; Ponz, OB; Díaz-Crespo, F; Fernández, IG; Seoane-Reula, ME.

Multidisciplinary approach to early identification of inborn errors of immunity in patients with lymphoproliferation

LEUKEMIA & LYMPHOMA. 2026; : Nº de citas: 1 [doi:10.1080/10428194.2026.2704265]

Maffini, E; Labopin, M; Raiola, AM; Blaise, D; Bramanti, S; Sica, S; Koc, Y; Kwon, M; Itäla-Remes, M; Martino, M; Corral, LL; Pavlu, J; Bruno, B; Spyridonidis, A; Savani, B; Nagler, A; Ciceri, F; Mohty, M.

Allogeneic hematopoietic cell transplantation from haploidentical donors with total body irradiation versus chemo-based regimens for adult AML patients in first complete remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

BONE MARROW TRANSPLANTATION. 2026; : [doi:10.1038/s41409-026-02988-w]

Sebastián, ID; De Córdoba-Oñate, SF; Bastos-Oreiro, M; Fernández-González, R; López-Esteban, M; Bailén, R; Gómez-Centurión, I; Fuentes, D; Anguita, J; Kwon, M; García-Sanz, R; Buño, I; Martínez-Laperche, C.

Transcriptomic landscape of peripheral T cells following CAR-T cell therapy in diffuse large B cell lymphoma

CANCER IMMUNOLOGY IMMUNOTHERAPY. 2026; 75(10): [doi:10.1007/s00262-026-04444-6]

Baile, R; Peña-Muñoz, F; Bermúdez, A; López-Corral, L; Fox, L; de Miguel, C; Asensi, P; Martín-González, J; Pascual-Cacón, MJ; Chinea, A; González-Sierra, P; Izquierdo, I; Calbacho, M; Vázquez, J; Ceballos, C; Morales-Curbelo, A; Sanchez-Salina, A; Zanabili, J; Sisinni, L; González-Vicent, M; Castilla, L; Balsalobre, P; Kwon, M.

Spanish Real-World Experience with Belumosudil for Chronic Graft-versus-Host Disease after 2 or More Prior Lines of Therapy

Transplantation and Cellular Therapy. 2026; 32(7): 864-864 [doi:10.1016/j.jtct.2026.03.001]

Donà, D; Liberati, C; Aidala, E; Bekassy, Z; Bjerre, A; Bordon, V; Sanchez, DB; Bouts, AHM; Bravo-Gallego, LY; Casotti, V; Catalano, S; Costa-Reis, P; Cucinotta, U; Debray, D; De Jong, H; De la Cerda-ojeda, F; De la Serna, O; Ferreira, S; Fischler, B; Guereta, LG; Gil, N; Vincent, MG; Gran-Ipiña, F; Grenda, R; Grima, D; Herden, U; Hierro, ML; Huerta, J; Jahnukainen, T; Jankauskiene, A; Kalicinski, P; Kötz, K; Lopes, MF; Gonzales, ML; Madrid, A; Mercadal-Hally, M; Marsal, J; Marzollo, A; Mellgren, K; Mendoza-Palomar, N; Mutschler, F; Odermarsky, M; De Mendoza, JMP; Peruzzi, L; Pietrobattista, A; Pinon, M; Prytula, A; Ramos, EB; Ranucci, G; Rascon, J; Saglio, F; Sandes, AR; Sciveres, M; Schwerk, N; Sharif, K; Sorensen, SS; Stephenne, X; Sweeney, C; Texeira, A; Tepel, M; Turkiewicz, D; Vainumae, I; Verma, A; Wåhlander, H; Warrington, A; Wennberg, L; Westphal, S; Willemse, BWM; Wolfs, T; Zarauza, A; Benetti, E; Hernández-Oliveros, F.

Antimicrobial Prophylaxis in Solid Organ and Hematopoietic Stem Cell Transplantation: A Survey Among Member Centers of the European Reference Network TransplantChild

PEDIATRIC TRANSPLANTATION. 2026; 30(7): Nº de citas: 1 [doi:10.1111/petr.70379]

Chavez, JC; Bastos-Oreiro, M; Diefenbach, C; Lossos, IS; Shah, NR; Assouline, S; Olszewski, AJ; Naik, S; Ghosh, N; Pham, S; Wei, MC; Batlevi, C; To, I; Ead, W; Makadia, S; Penuel, E; Jing, J; Budde, LE.

A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B-Cell Lymphoma

AMERICAN JOURNAL OF HEMATOLOGY. 2026; 101(9): 2177-2189 [doi:10.1002/ajh.70403]

Roboz, GJ; Zeidan, AM; Mannis, GN; Montesinos, P; Arnan, M; Savona, MR; Odenike, O; McCloskey, JK; Amin, HV; Fathi, AT; del Castillo, TB; Rodríguez-Macías, G; Liesveld, JL; Im, AP; Cerny, J; Gentile, TC; Oganesian, A; Chan, DN; Wan, YB; Dijkstra, M; Keer, HN; Griffiths, EA; DiNardo, CD.

All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia

NEW ENGLAND JOURNAL OF MEDICINE. 2026; 394(21): 2107-2116 Nº de citas: 8 [doi:10.1056/NEJMoa2510223]

Rodríguez-Veiga R; Gil C; Sobas M; Torres-Miñana L; Botella C; De la Serna J; Bernal T; Salamero O; Otero C; Navarro-Vicente I; De Miguel C; Garrido A; Vives S; Bergua J; Pérez-Encinas M; Algarra L; González-Campos J; Gómez MDMC; Prates MV; Benavente C; Tormo M; Cervera M; Fazio P; Amutio ME; García R; Pomares H; Vidriales B; Serrano J; Amigo ML; Rubio V; Almela Á; Barrios M; Sossa-Melo CL; Paluszewska M; Novo A; Gromek T; Rodríguez-Macías G; Oleksiuk J; Lloret-Madrid P; Montesinos P.

A scoring system to predict life-threatening thromboischemic events in patients with acute promyelocytic leukemia: the PETHEMA/PALG study.

HAEMATOLOGICA. 2026; 111(6): 2011-2022 [doi:10.3324/haematol.2025.288112]

Kuhlen, M; Roganivic, J; Naviglio, S; Baecklund, F; Bello, R; Ben-Ami, T; Bergamaschi, L; Bilic, E; Bien, E; Brito, MJ; Castañeda, A; Mazic, MC; Farinha, NJD; Jovanovska, A; de Krijger, R; de Pasquale, MD; Elisei, R; Bolado, GG; Guillén, G; Haissaguerre, M; Hartl, D; Huerta-Aragonés, J; Krawczyk, MA; Lamartina, L; Leite, F; Leite, V; Almaraz, RL; Manevska, N; Mansuy, L; Miele, E; Naderi, EH; Winther, TN; Petit, IO; Özön, ZA; Podda, MG; Pourtsidis, A; Reguerre, Y; Sandström, M; Schneider, DT; Ekinci, S; Omladic, JS; Sztangierska, B; Verite, C; Waespe, N; Wong, KH; Yalcin, B; Abele, M; Bisogno, G; Orbach, D; Brecht, IB; Virgone, C; Redlich, A.

Who leads, who treats, what dose? European paediatric differentiated thyroid carcinoma practice-an European Cooperative Study Group for Paediatric Rare Tumours survey

EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2026; 194(6): 756-768 [doi:10.1093/ejendo/lvag091]

Rubio-San-Simon, A; Cesari, M; Bear, M; Mata, C; Arakama, A; Knoderer, H; Sykes, A; Boss, J; van Hal, G; Italiano, A.

A Randomized, open-label, phase 2 study evaluating abemaciclib in combination with irinotecan and temozolomide in patients with relapsed or refractory Ewing sarcoma

EJC Paediatric Oncology. 2026; 7: [doi:10.1016/j.ejcped.2026.100525]